2008
DOI: 10.2478/s11535-008-0042-5
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of a synthetic siRNA delivery for the treatment of rhabdomyosarcoma

Abstract: Silencing of a target-genes by small interfering RNA (siRNA) has emerged as a powerful new tool not only for basic research but also with potential therapeutic benefits. This paper demonstrates that optimal delivery strategy is crucial for effective target-gene silencing. Using lipofection, under defined conditions, we were able to markedly down-regulate expression of the selected genes involved in rhabdomyosarcoma metastasis: MET, CXCR4, LIFR and PAX3-FKHR.© Versita Warsaw and Springer-Verlag Berlin Heidelber… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…In the present study, thiolated and nonthiolated TMC (Figure 1) were investigated for siRNA delivery and gene silencing. The silencing activity and the cellular toxicity of polyplexes based on these biodegradable polymers were compared with those based on the regularly used lipidic transfection agent Lipofectamine (35).…”
Section: Introductionmentioning
confidence: 99%
“…In the present study, thiolated and nonthiolated TMC (Figure 1) were investigated for siRNA delivery and gene silencing. The silencing activity and the cellular toxicity of polyplexes based on these biodegradable polymers were compared with those based on the regularly used lipidic transfection agent Lipofectamine (35).…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, lncRNAs that are found in body fluids have demonstrated a utility to be used as fluidbased non-invasive markers for clinical use. Therapeutic benefit can be obtained through RNA-based therapeutic strategies, such as siRNA and microRNA, or using small molecule compounds designed specifically to interact with target lncRNAs or ribonucleoprotein complexes [47]. It is tempting to speculate that a multitude of lncRNAs may interrupt specific steps in numerous tumor suppressive and oncogenic pathways.…”
Section: Resultsmentioning
confidence: 99%